Skip to main content
Premium Trial:

Request an Annual Quote

RainDance, Ambry Partner on Sequencing Applications

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics will offer services for sequence enrichment and resequencing validation using RainDance Technologies' RDT 1000 system, the firms announced today at the CHI Next Generation Sequencing Conference in San Diego.

The firms said that researchers can use the RDT 1000, a microdroplet PCR-based system, with Ambry Genetics' next generation services to reduce study time or improve study quality by running more samples in the same amount of time. They also said that Ambry may add Methyl-Seq and Ultra-Deep Resequencing applications in the second half of 2010.

"PCR is the gold standard for sequence enrichment and allows for high-resolution analysis of rare genetic variations, a focus area of Ambry Genetics' customers," Chris McNary, Chief Commercial Officer of Lexington, Mass.-based RainDance Technologies, said in a statement.

Last month, RainDance inked an alliance with Life Technologies under which the firms agreed to market RainDance's RDT 1000 Sequence Enrichment Solution with Applied Biosystems' SOLiD System next generation sequencer.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.